Eisai U.S. Unit, Poland Maker Ally For Targeted Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
Eisai's U.S. unit and Selvita of Poland have signed an agreement to develop targeted cancer drugs by identifying genes responsible for cancer.